ABF-101

· Aptabio Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABF-101, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses [Phase 1]